ADAM DYE: Open Payments
NPI 1861754947 · ST GEORGE, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$482 in 24 payments from 12 companies in 2025. Trend: 2023 $254 · 2024 $366 · 2025 $482
Food & beverage: $482
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $109 |
| AstraZeneca Pharmaceuticals LP | 4 | $70 |
| Organon LLC | 3 | $56 |
| Inspire Medical Systems, Inc. | 2 | $51 |
| Boston Scientific Corporation | 2 | $43 |
| Amgen Inc. | 2 | $38 |
| PFIZER INC. | 1 | $24 |
| IBSA Pharma Inc. | 1 | $21 |
| Grifols USA, LLC | 1 | $20 |
| Medtronic, Inc. | 1 | $18 |
Products named: NEXPLANON, QULIPTA, INSPIRE, General - Pain Management, FARXIGA, VRAYLAR, AIRSUPRA, PREVNAR 20.
Industry payments across UT — which companies pay providers there.
